146 related articles for article (PubMed ID: 33944664)
1. Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis.
Gambichler T; Özsoy O; Bui D; Scheel CH; Susok L
J Dermatolog Treat; 2022 Jun; 33(4):1979-1982. PubMed ID: 33944664
[TBL] [Abstract][Full Text] [Related]
2. The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study.
Papp G; Horvath IF; Gyimesi E; Barath S; Vegh J; Szodoray P; Zeher M
Immunol Res; 2016 Apr; 64(2):404-11. PubMed ID: 26168768
[TBL] [Abstract][Full Text] [Related]
3. Photopheresis: Advances and Use in Systemic Sclerosis.
Zhou XA; Choi J
Curr Rheumatol Rep; 2017 Jun; 19(6):31. PubMed ID: 28466383
[TBL] [Abstract][Full Text] [Related]
4. Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis.
Topuzoglu S; Knobler R; Movadat O; Petkov V; Foedinger D; Just U; Pehamberger H; Jantschitsch C
Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):175-83. PubMed ID: 25495608
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal photopheresis for systemic sclerosis: A meta-analysis of randomized clinical trials.
Delbrück C; Gambichler T; Susok L; Peinemann F
Dermatol Ther; 2022 Jul; 35(7):e15530. PubMed ID: 35445504
[TBL] [Abstract][Full Text] [Related]
6. Use of Extracorporeal Photopheresis in Scleroderma: A Review.
Du AX; Osman M; Gniadecki R
Dermatology; 2020; 236(2):105-110. PubMed ID: 31362294
[TBL] [Abstract][Full Text] [Related]
7. The effects of extracorporeal photochemotherapy on T cell activation and regulatory mechanisms in patients with systemic sclerosis.
Papp G; Barath S; Szegedi A; Szodoray P; Zeher M
Clin Rheumatol; 2012 Sep; 31(9):1293-9. PubMed ID: 22706443
[TBL] [Abstract][Full Text] [Related]
8. Management of severe scleroderma with long-term extracorporeal photopheresis.
Krasagakis K; Dippel E; Ramaker J; Owsianowski M; Orfanos CE
Dermatology; 1998; 196(3):309-15. PubMed ID: 9621138
[TBL] [Abstract][Full Text] [Related]
9. Impact of extracorporeal photopheresis on blood and coagulation parameters.
Gambichler T; Chatzipantazi M; Stranzenbach R; Feldkamp A; Susok L
Dermatol Ther; 2022 May; 35(5):e15366. PubMed ID: 35141988
[TBL] [Abstract][Full Text] [Related]
10. [Immunological monitoring of the efficacy of extracorporeal photopheresis for prevention of kidney transplant rejection].
Faenko AP; Chuksina YY; Zulkarnayev AB; Fedulkina VA; Vatazin AV; Kantaria RO
Urologiia; 2020 Sep; (4):73-78. PubMed ID: 32897018
[TBL] [Abstract][Full Text] [Related]
11. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis.
Papp G; Horvath IF; Barath S; Gyimesi E; Vegh J; Szodoray P; Zeher M
Clin Immunol; 2012 Feb; 142(2):150-9. PubMed ID: 22036269
[TBL] [Abstract][Full Text] [Related]
13. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
Stevens SR; Baron ED; Masten S; Cooper KD
Arch Dermatol; 2002 Oct; 138(10):1347-50. PubMed ID: 12374541
[TBL] [Abstract][Full Text] [Related]
14. Outcome of extracorporeal photopheresis in mycosis fungoides patients is not predicted by quotients of systemic immune-inflammatory biomarkers.
Gambichler T; Späth J; Said S; Scheel CH; Susok L; Stranzenbach R
J Clin Apher; 2022 Aug; 37(4):360-366. PubMed ID: 35352389
[TBL] [Abstract][Full Text] [Related]
15. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance.
Kusztal M; Kłak R; Krajewska M; Boratyńska M; Patrzałek D; Klinger M
Transplant Proc; 2011 Oct; 43(8):2941-2. PubMed ID: 21996195
[TBL] [Abstract][Full Text] [Related]
16. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
[TBL] [Abstract][Full Text] [Related]
17. Impact of Extracorporeal Photopheresis on Blood Parameters of Atopic Dermatitis Patients.
Gambichler T; Steinbrecht K; Chatzipantazi M; Scheel CH; Stranzenbach R; Schmitz L; Susok L
Dermatitis; 2022 Nov-Dec 01; 33(6S):S37-S42. PubMed ID: 34967772
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C
Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024
[TBL] [Abstract][Full Text] [Related]
19. [Progressive systemic sclerosis - treatment results of extracorporeal photopheresis].
Wollina U; Oelzner S; Looks A; Hipler UC; Knöll B; Lange D; Balogh A; Merkel U; Hein G; Oelzner P; Uhlemann C; Vogelsang H
Hautarzt; 1999 Sep; 50(9):637-42. PubMed ID: 10501679
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
Del Fante C; Scudeller L; Oggionni T; Viarengo G; Cemmi F; Morosini M; Cascina A; Meloni F; Perotti C
Respiration; 2015; 90(2):118-28. PubMed ID: 26112178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
